2013 AMSN Virtual Convention

Diabetes Mellitus Update 2013

Sep 28, 2013 3:00pm ‐ Sep 28, 2013 4:15pm


Description

This session provides an update on diabetes mellitus and its related complications. Pathophysiology and pharmacotherapy relative to medical-surgical nursing practice is also shared, as well as information about the newer incretin-based therapies used in the treatment of DM.

Contact hours available until 9/29/2015.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Conflict of Interest Disclosure:
Speaker(s) have no disclosures to declare.

Planning Committee members have no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:

This educational activity has been co-provided by Anthony J. Jannetti, Inc. and Academy of Medical-Surgical Nurses.

Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC-COA).

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered nursing, Provider Number, CEP 5387.

Objectives:

  • Review physiology of glucose homeostasis.
  • Review the diagnostic criteria for diabetes mellitus.
  • Describe the pathophysiology of diabetes, including macrovascular, microvascular, and neuropathic alterations.
  • Review the therapeutic regimen for treatment of diabetes, such as insulin and traditional medications.
  • Discuss the role of the newer incretin-based therapies in the treatment of diabetes.

Speaker(s):

  • Joan Frizzell, PhD, CRNP, ANP-BC, Critical Care Clinical Nurse Specialist and Manager, Roxborough Memorial Hospital

You must be logged in and own this session in order to post comments.